Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
ANL compared with BBOT: revenue, margins and what each company keeps, and the suppliers and customers both name
ANL
Adlai Nortye Ltd.
Change
Mkt cap
Revenue
Revenue
BBOT
BridgeBio Oncology Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
ANL
Adlai Nortye Ltd.
vs
BBOT
BridgeBio Oncology Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
ANL
No earnings history for ANL.
BBOT
1 of 4 reports
Report
implied
realized
× implied
Q2 FY26
—
▲
+2.39%
—
= implied
ANL realized, solid
BBOT realized, hatched
One scale, both sides: full bar = 3%
× = |realized| ÷ implied
Source: market data
ANL
Adlai Nortye Ltd.
Change
10.28
▲
+6.17%
· post 10.28
Mkt cap
$986.1M
BBOT
BridgeBio Oncology Therapeutics, Inc.
Change
2.02
▼
−6.83%
· post 2.08
Closed
Nov 6 '26
Mkt cap
$163.3M
vs
Compare
Closed
Nov 6 '26
ANL
Adlai Nortye Ltd.
vs
BBOT
BridgeBio Oncology Therapeutics, Inc.
10.28
▲
+6.17%
post 10.28
Price
2.02
▼
−6.83%
post 2.08
$986.1M
Mkt cap
$163.3M
Change
Change
ANL
10.28
▲
+6.17%
vs
BBOT
2.02
▼
−6.83%
Closed
Nov 6 '26